Hematopoietic Stem Cell Expansion in 3D Hydrogel

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for obtaining hematopoietic stem cells (HSCs) are invasive, risky, and inefficient, involving multiple injections of growth factors and extensive blood collection, which can lead to adverse reactions and are time-consuming.

Innovation Solution

The method involves obtaining a sample of yellow bone marrow, dividing it into small pieces, embedding them in a 3-dimensional hydrogel with a pro-angiogenic and stem cell-promoting medium, and culturing them to expand HSCs, which can then be isolated and differentiated into various blood cell types.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current methods for obtaining HSCs are used (multiple injections of growth factors and extensive blood collection), then HSCs can be obtained, but the procedures are invasive, risky, time-consuming, and can lead to adverse reactions

Engineering Contradiction:
Improvesafety of HSC collection procedureVSAvoidinvasiveness of procedure
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The invention extracts HSCs directly from bone marrow tissue samples obtained through a single minimally invasive biopsy procedure, eliminating the need for multiple invasive injections and extensive blood collection. The bone marrow sample is processed in vitro to expand HSCs, thereby extracting the desired cells from a small initial sample without requiring repeated invasive procedures on the patient.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention performs preliminary expansion of HSCs in vitro from a small bone marrow sample before administration. This preliminary action in the laboratory allows a minimal initial biopsy to yield sufficient HSCs for therapy, avoiding the need for multiple invasive collection procedures and extensive blood draws that would otherwise be required.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If current methods for obtaining HSCs are used, then HSCs can be obtained, but the procedures are time-consuming

Engineering Contradiction:
Improveefficiency of HSC productionVSAvoidduration of HSC collection process
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention performs preliminary expansion of HSCs in vitro from a small bone marrow sample before administration. This preliminary action in the laboratory allows a minimal initial biopsy to yield sufficient HSCs for therapy, avoiding the need for multiple invasive collection procedures and extensive blood draws that would otherwise be required.

Inventive Principle:
Principle #10Preliminary action

3Productivity

If yellow bone marrow is used as a source, then HSCs can be expanded efficiently, but the method requires development of new culture techniques

Engineering Contradiction:
Improveexpansion efficiency of HSCsVSAvoidcomplexity of culture system
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention uses a universal culture system based on hydrogel matrices and growth factor cocktails that can expand multiple types of stem cells (HSCs, mesenchymal stem cells, endothelial progenitors) from a single bone marrow sample. This multi-functional culture approach achieves high expansion efficiency while using established laboratory techniques rather than requiring entirely new complex systems.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Data Source

PatentUS20250145954A1Expansion of human hematopoietic stem cells from human yellow bone marrow
Publication Date: 2025.05.08 UNIV OF MASSACHUSETTS
  • US20250145954A1 patent drawing
  • US20250145954A1 patent drawing
  • US20250145954A1 patent drawing

AI summary

Hematopoietic stem cells (HSC) are essential to developing a functional immune system, including monocyte-macrophage cells required for wound healing. Described herein are methods of using yellow bone marrow as a source of cells to generate hematopoietic stem cells. The methods include expansion of human hematopoietic stem cells by culture of human yellow bone marrow in 3-dimensional hydrogel and pro-angiogenic, stem cell-promoting medium.